Oral Antithrombotic Use Among Myocardial Infarction Patients
OBJECTIVE To examine the use of oral antithrombotics (i.e., antiplatelet agents, oral anticoagulants) after myocardial infarction (MI) in the Netherlands from 1988 to 1998. METHODS Retrospective follow-up of 3800 patients with MI, using data from the PHARMO Record Linkage System. RESULTS From 1988 t...
Gespeichert in:
| Veröffentlicht in: | The Annals of pharmacotherapy 2003-01, Vol.37 (1), p.143-146 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 146 |
|---|---|
| container_issue | 1 |
| container_start_page | 143 |
| container_title | The Annals of pharmacotherapy |
| container_volume | 37 |
| creator | van der Elst, Menno E Cisneros-Gonzalez, Nelly de Blaey, Cornelis J Buurma, Henk de Boer, Anthonius |
| description | OBJECTIVE
To examine the use of oral antithrombotics (i.e., antiplatelet agents, oral anticoagulants) after myocardial infarction (MI) in the Netherlands from 1988 to 1998.
METHODS
Retrospective follow-up of 3800 patients with MI, using data from the PHARMO Record Linkage System.
RESULTS
From 1988 to 1998, oral antithrombotic treatment increased significantly from 54.0% to 88.9%. In 1998, only 75.8% of patients who experienced a MI in the late 1980s received oral antithrombotic treatment compared with 94.4% of those who experienced a recent MI.
CONCLUSIONS
Oral antithrombotics were considerably underused in patients with a past history of MI. Therefore, these patients should be reviewed for antithrombotic therapy to assess whether their failure to use oral antithrombotics was right or wrong, and whether treatment should be initiated if possible. |
| doi_str_mv | 10.1345/aph.1C038 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_72934351</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1345_aph.1C038</sage_id><sourcerecordid>72934351</sourcerecordid><originalsourceid>FETCH-LOGICAL-c407t-5a953041c27e25b4b3d2ed90ecd48cb76f3db27fba5f99694af42e925da4e1503</originalsourceid><addsrcrecordid>eNptkEtLAzEUhYMovhf-AZmNgoupN69OA25K8QUVXeg63Mlk2sjMpCZTSv-9UQe6cXXv4uOcw0fIBYUR5ULe4mo5ojPgkz1yTKVg-ZgVsJ9-GEMObAJH5CTGTwBQlKlDckSZBK4kHJO714BNNu161y-Db0vfO5N9RJtNW98tspetNxgql5jnrsZgeue77A17Z7s-npGDGptoz4d7Sj4e7t9nT_n89fF5Np3nRkDR5xKV5CCoYYVlshQlr5itFFhTiYkpi3HNq5IVdYmyVmqsBNaCWcVkhcLStPSUXP_lroL_WtvY69ZFY5sGO-vXURdMccElTeDNH2iCjzHYWq-CazFsNQX9o0onVfpXVWIvh9B12dpqRw5uEnA1ABgNNnXAzri440TBJgzYbl3EhdWffh26JOPfxiFw6RbLjQtWxxabJvVTvdlseKFpSuX8GxdVidw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>72934351</pqid></control><display><type>article</type><title>Oral Antithrombotic Use Among Myocardial Infarction Patients</title><source>Access via SAGE</source><source>MEDLINE</source><creator>van der Elst, Menno E ; Cisneros-Gonzalez, Nelly ; de Blaey, Cornelis J ; Buurma, Henk ; de Boer, Anthonius</creator><creatorcontrib>van der Elst, Menno E ; Cisneros-Gonzalez, Nelly ; de Blaey, Cornelis J ; Buurma, Henk ; de Boer, Anthonius</creatorcontrib><description>OBJECTIVE
To examine the use of oral antithrombotics (i.e., antiplatelet agents, oral anticoagulants) after myocardial infarction (MI) in the Netherlands from 1988 to 1998.
METHODS
Retrospective follow-up of 3800 patients with MI, using data from the PHARMO Record Linkage System.
RESULTS
From 1988 to 1998, oral antithrombotic treatment increased significantly from 54.0% to 88.9%. In 1998, only 75.8% of patients who experienced a MI in the late 1980s received oral antithrombotic treatment compared with 94.4% of those who experienced a recent MI.
CONCLUSIONS
Oral antithrombotics were considerably underused in patients with a past history of MI. Therefore, these patients should be reviewed for antithrombotic therapy to assess whether their failure to use oral antithrombotics was right or wrong, and whether treatment should be initiated if possible.</description><identifier>ISSN: 1060-0280</identifier><identifier>EISSN: 1542-6270</identifier><identifier>DOI: 10.1345/aph.1C038</identifier><identifier>PMID: 12503950</identifier><identifier>CODEN: APHRER</identifier><language>eng</language><publisher>Los Angeles, CA: Harvey Whitney Books</publisher><subject>Administration, Oral ; Anticoagulants - therapeutic use ; Biological and medical sciences ; Drug Therapy, Combination ; Drug Utilization ; Humans ; Medical sciences ; Myocardial Infarction - drug therapy ; Platelet Aggregation Inhibitors - therapeutic use ; Retrospective Studies</subject><ispartof>The Annals of pharmacotherapy, 2003-01, Vol.37 (1), p.143-146</ispartof><rights>2003 SAGE Publications</rights><rights>2003 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c407t-5a953041c27e25b4b3d2ed90ecd48cb76f3db27fba5f99694af42e925da4e1503</citedby><cites>FETCH-LOGICAL-c407t-5a953041c27e25b4b3d2ed90ecd48cb76f3db27fba5f99694af42e925da4e1503</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://journals.sagepub.com/doi/pdf/10.1345/aph.1C038$$EPDF$$P50$$Gsage$$H</linktopdf><linktohtml>$$Uhttps://journals.sagepub.com/doi/10.1345/aph.1C038$$EHTML$$P50$$Gsage$$H</linktohtml><link.rule.ids>314,780,784,4024,21819,27923,27924,27925,43621,43622</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=14728202$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12503950$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>van der Elst, Menno E</creatorcontrib><creatorcontrib>Cisneros-Gonzalez, Nelly</creatorcontrib><creatorcontrib>de Blaey, Cornelis J</creatorcontrib><creatorcontrib>Buurma, Henk</creatorcontrib><creatorcontrib>de Boer, Anthonius</creatorcontrib><title>Oral Antithrombotic Use Among Myocardial Infarction Patients</title><title>The Annals of pharmacotherapy</title><addtitle>Ann Pharmacother</addtitle><description>OBJECTIVE
To examine the use of oral antithrombotics (i.e., antiplatelet agents, oral anticoagulants) after myocardial infarction (MI) in the Netherlands from 1988 to 1998.
METHODS
Retrospective follow-up of 3800 patients with MI, using data from the PHARMO Record Linkage System.
RESULTS
From 1988 to 1998, oral antithrombotic treatment increased significantly from 54.0% to 88.9%. In 1998, only 75.8% of patients who experienced a MI in the late 1980s received oral antithrombotic treatment compared with 94.4% of those who experienced a recent MI.
CONCLUSIONS
Oral antithrombotics were considerably underused in patients with a past history of MI. Therefore, these patients should be reviewed for antithrombotic therapy to assess whether their failure to use oral antithrombotics was right or wrong, and whether treatment should be initiated if possible.</description><subject>Administration, Oral</subject><subject>Anticoagulants - therapeutic use</subject><subject>Biological and medical sciences</subject><subject>Drug Therapy, Combination</subject><subject>Drug Utilization</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Myocardial Infarction - drug therapy</subject><subject>Platelet Aggregation Inhibitors - therapeutic use</subject><subject>Retrospective Studies</subject><issn>1060-0280</issn><issn>1542-6270</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNptkEtLAzEUhYMovhf-AZmNgoupN69OA25K8QUVXeg63Mlk2sjMpCZTSv-9UQe6cXXv4uOcw0fIBYUR5ULe4mo5ojPgkz1yTKVg-ZgVsJ9-GEMObAJH5CTGTwBQlKlDckSZBK4kHJO714BNNu161y-Db0vfO5N9RJtNW98tspetNxgql5jnrsZgeue77A17Z7s-npGDGptoz4d7Sj4e7t9nT_n89fF5Np3nRkDR5xKV5CCoYYVlshQlr5itFFhTiYkpi3HNq5IVdYmyVmqsBNaCWcVkhcLStPSUXP_lroL_WtvY69ZFY5sGO-vXURdMccElTeDNH2iCjzHYWq-CazFsNQX9o0onVfpXVWIvh9B12dpqRw5uEnA1ABgNNnXAzri440TBJgzYbl3EhdWffh26JOPfxiFw6RbLjQtWxxabJvVTvdlseKFpSuX8GxdVidw</recordid><startdate>20030101</startdate><enddate>20030101</enddate><creator>van der Elst, Menno E</creator><creator>Cisneros-Gonzalez, Nelly</creator><creator>de Blaey, Cornelis J</creator><creator>Buurma, Henk</creator><creator>de Boer, Anthonius</creator><general>Harvey Whitney Books</general><general>SAGE Publications</general><general>Whitney</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20030101</creationdate><title>Oral Antithrombotic Use Among Myocardial Infarction Patients</title><author>van der Elst, Menno E ; Cisneros-Gonzalez, Nelly ; de Blaey, Cornelis J ; Buurma, Henk ; de Boer, Anthonius</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c407t-5a953041c27e25b4b3d2ed90ecd48cb76f3db27fba5f99694af42e925da4e1503</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Administration, Oral</topic><topic>Anticoagulants - therapeutic use</topic><topic>Biological and medical sciences</topic><topic>Drug Therapy, Combination</topic><topic>Drug Utilization</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Myocardial Infarction - drug therapy</topic><topic>Platelet Aggregation Inhibitors - therapeutic use</topic><topic>Retrospective Studies</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>van der Elst, Menno E</creatorcontrib><creatorcontrib>Cisneros-Gonzalez, Nelly</creatorcontrib><creatorcontrib>de Blaey, Cornelis J</creatorcontrib><creatorcontrib>Buurma, Henk</creatorcontrib><creatorcontrib>de Boer, Anthonius</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The Annals of pharmacotherapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>van der Elst, Menno E</au><au>Cisneros-Gonzalez, Nelly</au><au>de Blaey, Cornelis J</au><au>Buurma, Henk</au><au>de Boer, Anthonius</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Oral Antithrombotic Use Among Myocardial Infarction Patients</atitle><jtitle>The Annals of pharmacotherapy</jtitle><addtitle>Ann Pharmacother</addtitle><date>2003-01-01</date><risdate>2003</risdate><volume>37</volume><issue>1</issue><spage>143</spage><epage>146</epage><pages>143-146</pages><issn>1060-0280</issn><eissn>1542-6270</eissn><coden>APHRER</coden><abstract>OBJECTIVE
To examine the use of oral antithrombotics (i.e., antiplatelet agents, oral anticoagulants) after myocardial infarction (MI) in the Netherlands from 1988 to 1998.
METHODS
Retrospective follow-up of 3800 patients with MI, using data from the PHARMO Record Linkage System.
RESULTS
From 1988 to 1998, oral antithrombotic treatment increased significantly from 54.0% to 88.9%. In 1998, only 75.8% of patients who experienced a MI in the late 1980s received oral antithrombotic treatment compared with 94.4% of those who experienced a recent MI.
CONCLUSIONS
Oral antithrombotics were considerably underused in patients with a past history of MI. Therefore, these patients should be reviewed for antithrombotic therapy to assess whether their failure to use oral antithrombotics was right or wrong, and whether treatment should be initiated if possible.</abstract><cop>Los Angeles, CA</cop><pub>Harvey Whitney Books</pub><pmid>12503950</pmid><doi>10.1345/aph.1C038</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1060-0280 |
| ispartof | The Annals of pharmacotherapy, 2003-01, Vol.37 (1), p.143-146 |
| issn | 1060-0280 1542-6270 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_72934351 |
| source | Access via SAGE; MEDLINE |
| subjects | Administration, Oral Anticoagulants - therapeutic use Biological and medical sciences Drug Therapy, Combination Drug Utilization Humans Medical sciences Myocardial Infarction - drug therapy Platelet Aggregation Inhibitors - therapeutic use Retrospective Studies |
| title | Oral Antithrombotic Use Among Myocardial Infarction Patients |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T12%3A35%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Oral%20Antithrombotic%20Use%20Among%20Myocardial%20Infarction%20Patients&rft.jtitle=The%20Annals%20of%20pharmacotherapy&rft.au=van%20der%20Elst,%20Menno%20E&rft.date=2003-01-01&rft.volume=37&rft.issue=1&rft.spage=143&rft.epage=146&rft.pages=143-146&rft.issn=1060-0280&rft.eissn=1542-6270&rft.coden=APHRER&rft_id=info:doi/10.1345/aph.1C038&rft_dat=%3Cproquest_cross%3E72934351%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=72934351&rft_id=info:pmid/12503950&rft_sage_id=10.1345_aph.1C038&rfr_iscdi=true |